Mechanism of tumor necrosis factor gene expression in the development of heart failure and cardiac hypertrophy
肿瘤坏死因子基因表达在心力衰竭和心肌肥厚发生过程中的机制
基本信息
- 批准号:12835001
- 负责人:
- 金额:$ 2.69万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Clinical observations indicate that the concentration of tumor necrosis factor (TNF) is elevated in patients with advanced heart failure or hypertrophic cardiomyopathy. However, the mechanisms for TNF production in the setting of these diseases are poorly understood. We recently showed that angiotensin II (ANGII) as well as mechanical stretch stimulate the production of TNF in cardiac fibroblasts. To extend these observations, we have examined the moleculer mechanisms by which ANGII up regulates TNFα gene expression. Using neonatal rat cardiac fibroblasts. Northern blot analysis showed that treatment with ANGII, endothelin-1 (ET1) or lipopolysaccharide (LPS) induced TNFαmRNA expression. These increase in TNFαmRNA level were regulated at transcriptional level as determined by luciferase activity of TNFα promoter gene. Progressive deletion analysis of TNFα promoter gene showed that the ANGII-responsive region lies between -100 to -70bp from the transcription start site. On the other hand, LPS-responsive region lies between -200 to -100bp. Further, mutation analysis indicated that the ANGII-responsive element could interact with Bs and NF-_KB, but the LPS-responsive element could interact with Sp1 . Additional studies were performed to evaluate the intracelluler signaling pathway associated LPS-induced TNFα gene expression. The increase of TNFαmRNA expression was attenuated by KT5823 which is a PKG specific inhibitor, whereas MAP kinase, PKA or PKC inhibitors had no effect on this response. Moreover, 8 bromo-cyclic GMP induced TNFαmRNA expression. We conclude that TNFα gene expression is transcriptionaly activated by ANGII, ET1 and LPS in cardiac fibroblasts. However, this response is mediated through different transcriptional factors by ANGII and LPS. Thus, the mechanisms for TNF production in heart failure or cardiac hypertrophy should differ from those in infectious disease. Further, PKGdependent signaling pathway may be important for this response.
临床观察表明,肿瘤坏死因子(TNF)的浓度升高,在晚期心力衰竭或肥厚型心肌病患者。然而,在这些疾病的背景下TNF产生的机制知之甚少。我们最近发现,血管紧张素II(ANGII)以及机械拉伸刺激心脏成纤维细胞中TNF的产生。为了扩展这些观察结果,我们研究了ANGII上调TNFα基因表达的分子机制。使用新生大鼠心脏成纤维细胞。北方印迹分析显示,血管紧张素Ⅱ、内皮素-1(ET-1)或脂多糖(LPS)均可诱导TNFαmRNA表达。TNFαmRNA水平的增加在转录水平上受到TNFα启动子基因荧光素酶活性的调节。对TNFα启动子基因进行性缺失分析表明,ANGII反应区位于距转录起始位点-100至-70bp之间。另一方面,LPS反应区位于-200至-100 bp之间。进一步的突变分析表明ANGII反应元件可以与Bs和NF-κ B相互作用,而LPS反应元件可以与Sp1相互作用。进行了额外的研究,以评价与LPS诱导的TNFα基因表达相关的细胞内信号传导途径。PKG特异性抑制剂KT 5823可抑制TNFαmRNA表达的增加,而MAP激酶、PKA或PKC抑制剂对TNFαmRNA表达的增加无影响。此外,8溴环GMP诱导TNFαmRNA表达。结论:ANG Ⅱ、ET 1和LPS可转录激活心肌成纤维细胞TNFα基因的表达。然而,这种反应是由ANGII和LPS通过不同的转录因子介导的。因此,心力衰竭或心脏肥大中TNF产生的机制应该与感染性疾病中的机制不同。此外,PKG依赖性信号通路可能对这种反应很重要。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Tanaka et al: "Induction of VEGF gene transcription by IL-1 β is mediated〜"J Mol Cell Caridol. 12. 1955-1967 (2000)
T. Tanaka 等人:“IL-1 β 介导 VEGF 基因转录〜” J Mol Cell Caridol. 12. 1955-1967 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka T, Kanda T, McManus BM, Kanai H, Akiyama H, Sekiguchi K, Yokoyama T, Kurabayashi M: "Overexpression of interluekin-6 aggravates viral myocarditis: Impaired increase in tumor necrosis factor-α"J Mol Cell Cardiol. 33. 1627-1635 (2001)
Tanaka T、Kanda T、McManus BM、Kanai H、Akiyama H、Sekiguchi K、Yokoyama T、Kurabayashi M:“白细胞介素 6 的过度表达会加重病毒性心肌炎:肿瘤坏死因子 - α 的增加受损”J Mol Cell Cardiol 33。 1627-1635 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka T, Kurabayashi M, Kanai H, Sekigichi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R: "Induction of VEGF gene transcription by IL-1 β is mediated through stress-activated MAP kinases and Sp 1 sites in cardiac myocytes"J Mol Cell Cardiol. 32. 1955
Tanaka T、Kurabayashi M、Kanai H、Sekigichi K、Aihara Y、Yokoyama T、Arai M、Kanda T、Nagai R:“IL-1 β 诱导 VEGF 基因转录是通过应激激活的 MAP 激酶和 Sp 1 位点介导的在心肌细胞中”J Mol Cell Cardiol. 32. 1955
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Arai et al.: "Mechanism of doxorubicin-induced inhibition of sarcoplasmic 〜"Circulation Res. 86. 8-14
M.Arai 等人:“阿霉素诱导的肌浆抑制机制 ~”循环研究 86. 8-14
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Sekiguchi et al.: "Homeobox protein Hex induces SMemb/nonmuscle myosin 〜"Circulation Res. 88. 52-58
K. Sekiguchi 等人:“同源框蛋白 Hex 诱导 SMemb/非肌肉肌球蛋白 ~”循环研究 88. 52-58
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOKOYAMA Tomoyuki其他文献
YOKOYAMA Tomoyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOKOYAMA Tomoyuki', 18)}}的其他基金
Mechanisms of cardiac dysfunction in metabolic syndrome
代谢综合征心功能障碍的机制
- 批准号:
18590761 - 财政年份:2006
- 资助金额:
$ 2.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of leptin receptor isoforms expression in heart diseases
瘦素受体亚型在心脏病中的表达机制
- 批准号:
16590658 - 财政年份:2004
- 资助金额:
$ 2.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of the tumor necrosis factor-α promoter in the development of heart failure
肿瘤坏死因子-α启动子在心力衰竭发展中的调节
- 批准号:
14570636 - 财政年份:2002
- 资助金额:
$ 2.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 2.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
HuR-Wisp1 signaling in cardiac fibroblasts
心脏成纤维细胞中的 HuR-Wisp1 信号传导
- 批准号:
10751223 - 财政年份:2023
- 资助金额:
$ 2.69万 - 项目类别:
Influence of thyroid hormone on collagen deposition by trout cardiac fibroblasts
甲状腺激素对鳟鱼心脏成纤维细胞胶原沉积的影响
- 批准号:
571829-2022 - 财政年份:2022
- 资助金额:
$ 2.69万 - 项目类别:
University Undergraduate Student Research Awards
The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing
Runx1在心肌成纤维细胞及心肌梗死后愈合中的作用
- 批准号:
10367400 - 财政年份:2021
- 资助金额:
$ 2.69万 - 项目类别:
The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing
Runx1在心肌成纤维细胞及心肌梗死后愈合中的作用
- 批准号:
10540749 - 财政年份:2021
- 资助金额:
$ 2.69万 - 项目类别:
Gene expression regulation mediating the activation and differentiation of cardiac fibroblasts and pulmonary fibroblasts after myocardial infarction
心肌梗死后介导心脏成纤维细胞和肺成纤维细胞活化和分化的基因表达调控
- 批准号:
10434447 - 财政年份:2021
- 资助金额:
$ 2.69万 - 项目类别:
Reparative macrophages contribute to development of solid replacement fibrosis through protecting cardiac fibroblasts
修复性巨噬细胞通过保护心脏成纤维细胞促进固体替代纤维化的发展
- 批准号:
20K09153 - 财政年份:2020
- 资助金额:
$ 2.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts
使用人类多能干细胞来源的心脏成纤维细胞改善心血管疾病模型
- 批准号:
10462472 - 财政年份:2020
- 资助金额:
$ 2.69万 - 项目类别:
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts
使用人类多能干细胞来源的心脏成纤维细胞改善心血管疾病模型
- 批准号:
10472759 - 财政年份:2020
- 资助金额:
$ 2.69万 - 项目类别:
Enhancer-based modulation of cardiac fibroblasts
基于增强子的心脏成纤维细胞调节
- 批准号:
428316638 - 财政年份:2019
- 资助金额:
$ 2.69万 - 项目类别:
Research Grants